SCHEMBL20176738

SCHEMBL20176738

Cc1cnn(-c2cc(C)c(C#N)cn2)n1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNJ1 P48048 11/20 0.41
KCNH2 Q12809 2/20 0.39
ABCB11 O95342 1/20 0.38
POU2F2 P09086 1/20 0.38
POU2F1 P14859 1/20 0.38
SLC47A1 Q96FL8 1/20 0.38
KDM4E B2RXH2 3/20 0.35
NPC1 O15118 1/20 0.35
ALDH1A1 P00352 1/20 0.35
RAB9A P51151 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
RXFP1 Q9HBX9 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
JAK2 O60674 1/20 0.33
JAK1 P23458 1/20 0.33
TYK2 P29597 1/20 0.33
JAK3 P52333 1/20 0.33
AR P10275 2/20 0.32
EGLN2 Q96KS0 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24135397 0.82 KCNJ1 (0.47) KCNJ1KCNH2ABCB11POU2F2POU2F1
SCHEMBL24135356 0.82 KCNJ1 (0.42) KCNJ1KCNH2ABCB11POU2F2POU2F1
SCHEMBL20168367 0.81 KCNJ1 (0.52) KCNJ1KCNH2ABCB11POU2F2POU2F1
SCHEMBL30445170 0.81 KCNJ1 (0.42) KCNJ1KCNH2ABCB11POU2F2POU2F1
SCHEMBL30444639 0.81 KCNJ1 (0.52) KCNJ1KCNH2ABCB11POU2F2POU2F1
SCHEMBL20168335 0.81 KCNJ1 (0.48) KCNJ1KCNH2ABCB11POU2F2POU2F1
SCHEMBL20168616 0.81 KCNJ1 (0.42) KCNJ1KCNH2ABCB11POU2F2POU2F1
SCHEMBL30445113 0.81 KCNJ1 (0.48) KCNJ1KCNH2ABCB11POU2F2POU2F1
SCHEMBL20168011 0.80 KCNJ1 (0.42) KCNJ1KCNH2ABCB11POU2F2POU2F1
SCHEMBL21266181 0.80 KCNJ1 (0.42) KCNJ1KCNH2ABCB11POU2F2POU2F1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3929194-A1 SUBSTITUTED NITROGEN CONTAINING COMPOUNDS Bristol-Myers Squibb Company (US) 2021-12-29 EP disclosed
WO-2018093569-A1 SUBSTITUTED BICYCLE HETEROCYCLIC DERIVATIVES USEFUL AS ROMK CHANNEL INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2018-05-24 WO disclosed